74 related articles for article (PubMed ID: 16412294)
1. [Effect of interleukin-8 in cell invasion and proliferation of human breast cancer].
Lin Y; Wang SM; Lü WM; Huang RP
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1541-4. PubMed ID: 16412294
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer.
Yao C; Lin Y; Ye CS; Bi J; Zhu YF; Wang SM
Chin Med J (Engl); 2007 Oct; 120(20):1766-72. PubMed ID: 18028768
[TBL] [Abstract][Full Text] [Related]
3. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
4. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
5. [Human breast myoepithelial cell blocks estrogen receptor-negative breast carcinoma cell invasion].
Shao Z; Shen Z
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):214-6. PubMed ID: 11601042
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
7. In vitro demonstration of breast cancer tumor cell sub-populations based on interleukin-1/tumor necrosis factor induction of interleukin-8 expression.
Pantschenko AG; Pushkar I; Miller LJ; Wang YP; Anderson K; Peled Z; Kurtzman SH; Kreutzer DL
Oncol Rep; 2003; 10(4):1011-7. PubMed ID: 12792762
[TBL] [Abstract][Full Text] [Related]
8. Role of ICAM1 in invasion of human breast cancer cells.
Rosette C; Roth RB; Oeth P; Braun A; Kammerer S; Ekblom J; Denissenko MF
Carcinogenesis; 2005 May; 26(5):943-50. PubMed ID: 15774488
[TBL] [Abstract][Full Text] [Related]
9. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
10. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
11. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.
Vazquez-Martin A; Colomer R; Menendez JA
Eur J Cancer; 2007 May; 43(7):1117-24. PubMed ID: 17379503
[TBL] [Abstract][Full Text] [Related]
12. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays.
Lin Y; Huang R; Chen L; Li S; Shi Q; Jordan C; Huang RP
Int J Cancer; 2004 Apr; 109(4):507-15. PubMed ID: 14991571
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
[TBL] [Abstract][Full Text] [Related]
14. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between expression of interleukin-8 and prognosis of breast cancer].
Yao C; Wang SM; Xie D; Wu HX; Chen DY; Lin Y
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):900-3. PubMed ID: 17067482
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro.
Wang XY; Tan JX; Vasse M; Delpech B; Ren GS
Chin Med J (Engl); 2009 Jun; 122(11):1300-4. PubMed ID: 19567141
[TBL] [Abstract][Full Text] [Related]
17. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
Schubert A; Schulz H; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
[TBL] [Abstract][Full Text] [Related]
18. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
20. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.
Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y
Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
